DMTK DermTech Inc

Price (delayed)

$5.61

Market cap

$167.97M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.16

Enterprise value

$43.19M

DermTech is the leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech's mission is to transform ...

Highlights
The revenue has surged by 90% year-on-year and by 10% since the previous quarter
DermTech's debt has soared by 197% from the previous quarter
The net income has dropped by 109% year-on-year and by 19% since the previous quarter

Key stats

What are the main financial stats of DMTK
Market
Shares outstanding
29.94M
Market cap
$167.97M
Enterprise value
$43.19M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.82
Price to sales (P/S)
12.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.31
Earnings
Revenue
$13.03M
EBIT
-$93.38M
EBITDA
-$90.47M
Free cash flow
-$79.57M
Per share
EPS
-$3.16
Free cash flow per share
-$2.67
Book value per share
$6.82
Revenue per share
$0.44
TBVPS
$8.03
Balance sheet
Total assets
$239.52M
Total liabilities
$36.04M
Debt
$23.3M
Equity
$203.48M
Working capital
$193.7M
Liquidity
Debt to equity
0.11
Current ratio
14.43
Quick ratio
14.36
Net debt/EBITDA
1.38
Margins
EBITDA margin
-694.2%
Gross margin
7%
Net margin
-716.5%
Operating margin
-722.7%
Efficiency
Return on assets
-36.1%
Return on equity
-39.2%
Return on invested capital
-141.8%
Return on capital employed
-41.5%
Return on sales
-716.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

DMTK stock price

How has the DermTech stock price performed over time
Intraday
1.63%
1 week
-0.71%
1 month
-21.43%
1 year
-87.11%
YTD
-64.49%
QTD
-61.78%

Financial performance

How have DermTech's revenue and profit performed over time
Revenue
$13.03M
Gross profit
$916,000
Operating income
-$94.18M
Net income
-$93.38M
Gross margin
7%
Net margin
-716.5%
The operating income has plunged by 126% YoY and by 22% from the previous quarter
The net income has dropped by 109% year-on-year and by 19% since the previous quarter
The revenue has surged by 90% year-on-year and by 10% since the previous quarter
The gross margin has contracted by 35% from the previous quarter

Growth

What is DermTech's growth rate over time

Valuation

What is DermTech stock price valuation
P/E
N/A
P/B
0.82
P/S
12.84
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.31
DermTech's EPS has decreased by 46% YoY and by 17% from the previous quarter
The price to book (P/B) is 95% lower than the 5-year quarterly average of 16.8 and 74% lower than the last 4 quarters average of 3.1
DermTech's equity has decreased by 21% YoY and by 11% from the previous quarter
The revenue has surged by 90% year-on-year and by 10% since the previous quarter
The stock's P/S is 83% below its last 4 quarters average of 73.1

Efficiency

How efficient is DermTech business performance
The return on equity has declined by 26% since the previous quarter but it is up by 6% year-on-year
The company's return on assets fell by 22% QoQ but it rose by 8% YoY
DermTech's ROS has decreased by 10% YoY and by 8% from the previous quarter
DermTech's return on invested capital has increased by 8% QoQ and by 8% YoY

Dividends

What is DMTK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for DMTK.

Financial health

How did DermTech financials performed over time
DermTech's total liabilities has soared by 94% from the previous quarter
DermTech's current ratio has shrunk by 61% YoY and by 24% QoQ
DermTech's debt is 89% less than its equity
DermTech's debt has soared by 197% from the previous quarter
DermTech's equity has decreased by 21% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.